medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2026-2-42-46medalphabet-5032Research ArticleСтатьиСовременные методы лечения цервикальной дистонии: роль физиотерапииContemporary management of cervical dystonia: the evolving role of physiotherapyСилинН. Л.SilinN. L.

Силин Никита Леонидович, врач-физиотерапевт отделения восстановительной медицины

Москва

Silin Nikita L., physiotherapist at Depat of Rehabilitation Medicine

Moscow

nikita-silin@mail.ruhttps://orcid.org/0000-0003-3489-7760ПрикулсВ. Ф.PrikulsV. F.

Прикулс Владислав Францевич, д. м. н., доцент, зав. кафедрой медицинской реабилитации и физиотерапии ФУВ

Москва

Prikuls Vladislav F., Dr Med Sci (habil.), associate professor, head of Dept of Medical Rehabilitation and Physiotherapy of the Faculty of Advanced Training

Moscow

ГБУЗ Московской области «Московский областной научно-исследовательский клинический институт им. М. Ф. Владимирского»РоссияM. F. Vladimirsky Moscow Regional Research and Clinical InstituteRussian Federation20261305202602Неврология и психиатрия (1)4246Copyright © Силин Н.Л., Прикулс В.Ф., 20262026Силин Н.Л., Прикулс В.Ф.Silin N.L., Prikuls V.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/5032

Цервикальная дистония – хроническое неврологическое заболевание, характеризующееся непроизвольными сокращениями мышц шеи, приводящими к патологическому положению головы, боли, тремору и значительному снижению качества жизни. Применение ботулинического токсина типа А (БТА) остается золотым стандартом лечения, однако ее ограниченная длительность действия (2–6 месяцев) является ключевой проблемой. В обзоре представлен анализ современных методов лечения ЦД: БТА, медикаментозная терапия, глубокая стимуляция мозга (ГСМ), хирургические методы, лечебная физкультура (ЛФК), транскраниальная электростимуляция (ТЭС). Особое внимание уделено новому перспективному направлению неинвазивной нейромодуляции – транскраниальной магнитной стимуляции (ТМС), обладающему значительным потенциалом для увеличения длительности эффекта БТА за счет воздействия на нейропластичность.

Cervical dystonia is a chronic neurological condition characterised by involuntary muscular contractions of the neck, resulting in abnormal head posture, pain, tremor, and a substantially diminished quality of life. Whilst the administration of botulinum toxin type A (BoNT-A) remains the established gold-standard intervention, its transient efficacy, typically lasting between two to six months, presents a principal therapeutic limitation. This review provides a critical analysis of current treatment modalities for cervical dystonia, namely BoNT-A therapy, pharmacological management, deep brain stimulation (DBS), surgical interventions, targeted exercise regimens, and transcranial electrical stimulation. Particular emphasis is placed on the emerging field of non-invasive neuromodulation, specifically repetitive transcranial magnetic stimulation (rTMS). This promising approach may hold significant potential for prolonging the therapeutic benefits of BoNT-A through the targeted induction of neuroplastic changes within the cortical circuitry.

цервикальная дистонияспастическая кривошеяботулинотерапияБТАЛФКфизическая реабилитациятранскраниальная магнитная стимуляцияТМСнейромодуляцияпродление эффектаcervical dystoniaspasmodic torticollisbotulinum toxin therapydeep brain stimulationphysiotherapyrehabilitationtranscranial magnetic stimulationneuromodulationneuroplasticityReferencesTyślerowicz M., Kiedrzyńska W., Adamkiewicz B., Jost W.H., Sławek J. Cervical dystonia – improving the effectiveness of botulinum toxin therapy. Neurol Neurochir Pol. 2020; 54 (3): 232–242. DOI: 10.5603/PJNNS.a2020.0021Tyślerowicz M., Kiedrzyńska W., Adamkiewicz B., Jost W.H., Sławek J. Cervical dystonia – improving the effectiveness of botulinum toxin therapy. Neurol Neurochir Pol. 2020; 54 (3): 232–242. DOI: 10.5603/PJNNS.a2020.0021Rosales R. L., Cuffe L., Regnault B., Trosch R. M. Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother. 2021; 21 (10): 1125–1134. DOI: 10.1080/14737175.2021.1984230Rosales R. L., Cuffe L., Regnault B., Trosch R. M. Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother. 2021; 21 (10): 1125–1134. DOI: 10.1080/14737175.2021.1984230Albanese A. и др. Isolated Cervical Dystonia: Diagnosis and Classification. Movement Disorders 2023; 38 (8): 1367–1378. DOI: 10.1002/mds.29387Albanese A. и др. Isolated Cervical Dystonia: Diagnosis and Classification. Movement Disorders 2023; 38 (8): 1367–1378. DOI: 10.1002/mds.29387O’Connor S., Hevey D., Burke T., Rafee S., Pender N., O’Keeffe F. A Systematic Review of Cognition in Cervical Dystonia. Neuropsychol Rev. 2024; 34 (1): 134–154. DOI: 10.1007/s11065-022-09558-zO’Connor S., Hevey D., Burke T., Rafee S., Pender N., O’Keeffe F. A Systematic Review of Cognition in Cervical Dystonia. Neuropsychol Rev. 2024; 34 (1): 134–154. DOI: 10.1007/s11065-022-09558-zDefazio G., Jankovic J., Giel J. L., Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (NY). 2013; 3: tre-03-193-4374-2. DOI: 10.7916/D80C4TGJDefazio G., Jankovic J., Giel J. L., Papapetropoulos S. Descriptive epidemiology of cervical dystonia. Tremor Other Hyperkinet Mov (NY). 2013; 3: tre-03-193-4374-2. DOI: 10.7916/D80C4TGJОрлова О.Р. и др. Клинические рекомендации: Дистония 2024.Orlova O.R. et al. Clinical Guidelines: Dystonia 2024. (In Russ.).Орлова О.Р., Яхно Н.Н. Применение ботокса (токсина ботулизма типа А) в клинической практике. Каталог, 2000. С. 208.Orlova O.R., Yakhno N.N. The use of Botox (botulinum toxin type A) in clinical practice. Catalogue 2000. P. 208. (In Russ.).Conte A., Defazio G., Hallett M., Fabbrini G., Berardelli A. The role of sensory information in the pathophysiology of focal dystonias. Nat Rev Neurol. 2019; 15 (4): 224–233. DOI: 10.1038/s41582-019-0137-9Conte A., Defazio G., Hallett M., Fabbrini G., Berardelli A. The role of sensory information in the pathophysiology of focal dystonias. Nat Rev Neurol. 2019; 15 (4): 224–233. DOI: 10.1038/s41582-019-0137-9Jinnah H.A., Hess E.J. Evolving concepts in the pathogenesis of dystonia. Parkinsonism Relat Disord. 2018; 46: S62–S65. DOI: 10.1016/j.parkreldis.2017.08.001Jinnah H.A., Hess E.J. Evolving concepts in the pathogenesis of dystonia. Parkinsonism Relat Disord. 2018; 46: S62–S65. DOI: 10.1016/j.parkreldis.2017.08.001Leodori G. и др. Muscle theta activity in the pathophysiology of cervical dystonia. Neurobiol Dis. 2025; 212: 106969. DOI: 10.1016/j.nbd.2025.106969Leodori G. и др. Muscle theta activity in the pathophysiology of cervical dystonia. Neurobiol Dis. 2025; 212: 106969. DOI: 10.1016/j.nbd.2025.106969Caverzasio S., Amato N., Chiaro G., Staedler C., Kaelin-Lang A., Galati S. Impairment of sleep homeostasis in cervical dystonia patients. Sci Rep. 2022; 12 (1): 6866. DOI: 10.1038/s41598-022-10802-yCaverzasio S., Amato N., Chiaro G., Staedler C., Kaelin-Lang A., Galati S. Impairment of sleep homeostasis in cervical dystonia patients. Sci Rep. 2022; 12 (1): 6866. DOI: 10.1038/s41598-022-10802-yDressler D., Kopp B., Pan L., Saberi F.A. The natural course of idiopathic cervical dystonia. J. Neural Transm. 2024; 131 (3): 245–252. DOI: 10.1007/s00702-023-02736-0Dressler D., Kopp B., Pan L., Saberi F.A. The natural course of idiopathic cervical dystonia. J. Neural Transm. 2024; 131 (3): 245–252. DOI: 10.1007/s00702-023-02736-0Rosales R. L., Cuffe L., Regnault B., Trosch R. M. Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother 2021; 21 (10): 1125–1134. DOI: 10.1080/14737175.2021.1984230Rosales R. L., Cuffe L., Regnault B., Trosch R. M. Pain in cervical dystonia: mechanisms, assessment and treatment. Expert Rev Neurother 2021; 21 (10): 1125–1134. DOI: 10.1080/14737175.2021.1984230Maione R., Formica C., Quartarone A., Lo Buono V. The Impact of Non-Motor Symptoms on Quality of Life in Cervical Dystonia. J. Clin Med. 2023; 12 (14): 4663. DOI: 10.3390/jcm12144663Maione R., Formica C., Quartarone A., Lo Buono V. The Impact of Non-Motor Symptoms on Quality of Life in Cervical Dystonia. J. Clin Med. 2023; 12 (14): 4663. DOI: 10.3390/jcm12144663Loens S. и др. Validation of clinical ratings of cervical dystonia using computer-generated avatars. Parkinsonism Relat Disord. 2025; 107975. DOI: 10.1016/j.parkreldis.2025.107975Loens S. и др. Validation of clinical ratings of cervical dystonia using computer-generated avatars. Parkinsonism Relat Disord. 2025; 107975. DOI: 10.1016/j.parkreldis.2025.107975Castagna A., Albanese A. Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance. Neurol Clin Pract. 2019; 9 (1): 64–73. DOI: 10.1212/CPJ.0000000000000568Castagna A., Albanese A. Management of cervical dystonia with botulinum neurotoxins and EMG/ultrasound guidance. Neurol Clin Pract. 2019; 9 (1): 64–73. DOI: 10.1212/CPJ.0000000000000568Ndukwe I., O’Riordan S., Walsh C.B., Hutchinson M. Trust the Patient Not the Doctor: The Determinants of Quality of Life in Cervical Dystonia. Front Neurol. 2020; Т. 11: 991. DOI: 10.3389/fneur.2020.00991Ndukwe I., O’Riordan S., Walsh C.B., Hutchinson M. Trust the Patient Not the Doctor: The Determinants of Quality of Life in Cervical Dystonia. Front Neurol. 2020; Т. 11: 991. DOI: 10.3389/fneur.2020.00991Klingelhoefer L. и др. Validation of a self-completed Dystonia Non-Motor Symptoms Questionnaire. Ann Clin Transl Neurol. 2019; 6 (10): 2054–2065. DOI: 10.1002/acn3.50900Klingelhoefer L. и др. Validation of a self-completed Dystonia Non-Motor Symptoms Questionnaire. Ann Clin Transl Neurol. 2019; 6 (10): 2054–2065. DOI: 10.1002/acn3.50900Erro R., Picillo M., Pellecchia M.T., Barone P. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review. Toxins (Basel). 2023; 15 (6): 391. DOI: 10.3390/toxins15060391Erro R., Picillo M., Pellecchia M.T., Barone P. Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review. Toxins (Basel). 2023; 15 (6): 391. DOI: 10.3390/toxins15060391Shipkov H. et al. Comparing Injection Methods of Botulinum Toxin A for Cervical Dystonia: A Systematic Review. Life 2025; 15 (6): 920. DOI: 10.3390/life15060920Shipkov H. et al. Comparing Injection Methods of Botulinum Toxin A for Cervical Dystonia: A Systematic Review. Life 2025; 15 (6): 920. DOI: 10.3390/life15060920Yahalom G., Fay-Karmon T., Livneh V., Israeli-Korn S., Ephraty L., Hassin-Baer S. Botulinum Injections for Idiopathic Cervical Dystonia: a Longitudinal Study. Neurotox Res. 2021; 39 (4): 1352–1359. DOI: 10.1007/s12640-021-00378-2Yahalom G., Fay-Karmon T., Livneh V., Israeli-Korn S., Ephraty L., Hassin-Baer S. Botulinum Injections for Idiopathic Cervical Dystonia: a Longitudinal Study. Neurotox Res. 2021; 39 (4): 1352–1359. DOI: 10.1007/s12640-021-00378-2Walter U., Albrecht P., Carr W., Hefter H. Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity With Botulinum Neurotoxin A in Multiple Indications. Eur J. Neurol. 2025; 32 (8): e70289. DOI: 10.1111/ene.70289Walter U., Albrecht P., Carr W., Hefter H. Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity With Botulinum Neurotoxin A in Multiple Indications. Eur J. Neurol. 2025; 32 (8): e70289. DOI: 10.1111/ene.70289Albanese A. и др. Definition and Classification of Dystonia. Movement Disorders 2025; 40 (7): 1248–1259. DOI: 10.1002/mds.30220Albanese A. и др. Definition and Classification of Dystonia. Movement Disorders 2025; 40 (7): 1248–1259. DOI: 10.1002/mds.30220Ortiz R., Scheperjans F., Mertsalmi T., Pekkonen E. The prevalence of adult-onset isolated dystonia in Finland 2007–2016. PLoS One 2018; 13 (11): e0207729. DOI: 10.1371/journal.pone.0207729Ortiz R., Scheperjans F., Mertsalmi T., Pekkonen E. The prevalence of adult-onset isolated dystonia in Finland 2007–2016. PLoS One 2018; 13 (11): e0207729. DOI: 10.1371/journal.pone.0207729Dashtipour K., Mari Z., Jankovic J., Adler C.H., Schwartz M., Brin M.F. Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study. J. Neurol Sci. 2019; 405: 116413. DOI: 10.1016/j.jns.2019.07.031Dashtipour K., Mari Z., Jankovic J., Adler C.H., Schwartz M., Brin M.F. Minimal clinically important change in patients with cervical dystonia: Results from the CD PROBE study. J. Neurol Sci. 2019; 405: 116413. DOI: 10.1016/j.jns.2019.07.031Chen S. Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments. Toxins (Basel). 2012; 4 (10): 913–939. DOI: 10.3390/toxins4100913Chen S. Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments. Toxins (Basel). 2012; 4 (10): 913–939. DOI: 10.3390/toxins4100913Carr W.W., Jain N., Sublett J.W. Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications. Adv Ther. 2021; 38 (10): 5046–5064. DOI: 10.1007/s12325-021-01882-9Carr W.W., Jain N., Sublett J.W. Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications. Adv Ther. 2021; 38 (10): 5046–5064. DOI: 10.1007/s12325-021-01882-9Volkmann J. и др. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014; 13 (9): 875–884. DOI: 10.1016/S1474-4422(14)70143-7Volkmann J. и др. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014; 13 (9): 875–884. DOI: 10.1016/S1474-4422(14)70143-7Trosch R.M. и др. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry. J. Neurol Sci. 2017; 376: 84–90. DOI: 10.1016/j.jns.2017.02.042Trosch R.M. и др. Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry. J. Neurol Sci. 2017; 376: 84–90. DOI: 10.1016/j.jns.2017.02.042Jinnah H.A. Medical and Surgical Treatments for Dystonia. Neurol Clin. 2020; 38 (2): 325–348. DOI: 10.1016/j.ncl.2020.01.003Jinnah H.A. Medical and Surgical Treatments for Dystonia. Neurol Clin. 2020; 38 (2): 325–348. DOI: 10.1016/j.ncl.2020.01.003Andre L., Gallini A., Montastruc F., Montastruc J.-L., Piau A., Lapeyre-Mestre M., Gardette V. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review. Eur. J. Clin Pharmacol. 2019; 75 (12): 1631–1644. DOI: 10.1007/s00228-019-02744-8Andre L., Gallini A., Montastruc F., Montastruc J.-L., Piau A., Lapeyre-Mestre M., Gardette V. Association between anticholinergic (atropinic) drug exposure and cognitive function in longitudinal studies among individuals over 50 years old: a systematic review. Eur. J. Clin Pharmacol. 2019; 75 (12): 1631–1644. DOI: 10.1007/s00228-019-02744-8Tsuboi T., Cauraugh J.H., Wong J.K., Okun M.S., Ramirez-Zamora A. Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis. J. Neurol Neurosurg Psychiatry. 2020; 91 (9): 938–944. DOI: 10.1136/jnnp-2019-322575Tsuboi T., Cauraugh J.H., Wong J.K., Okun M.S., Ramirez-Zamora A. Quality of life outcomes after globus pallidus internus deep brain stimulation in idiopathic or inherited isolated dystonia: a meta-analysis. J. Neurol Neurosurg Psychiatry. 2020; 91 (9): 938–944. DOI: 10.1136/jnnp-2019-322575Tsuboi T., Wong J.K., Almeida L., Hess C.W., Wagle Shukla A., Foote K.D., Okun M.S., Ramirez-Zamora A. A pooled meta-analysis of GPi and STN deep brain stimulation outcomes for cervical dystonia. J. Neurol. 2020; 267 (5): 1278–1290. DOI: 10.1007/s00415-020-09703-9Tsuboi T., Wong J.K., Almeida L., Hess C.W., Wagle Shukla A., Foote K.D., Okun M.S., Ramirez-Zamora A. A pooled meta-analysis of GPi and STN deep brain stimulation outcomes for cervical dystonia. J. Neurol. 2020; 267 (5): 1278–1290. DOI: 10.1007/s00415-020-09703-9Khanom A.A., Franceschini P.R., Lane S., Osman-Farah J., Macerollo A. Bilateral globus pallidus internus (GPi) deep brain stimulation for cervical dystonia: Effects on motor and non-motor symptoms within 5 years follow. J. Neurol Sci. 2023; 452: 120752. DOI: 10.1016/j.jns.2023.120752Khanom A.A., Franceschini P.R., Lane S., Osman-Farah J., Macerollo A. Bilateral globus pallidus internus (GPi) deep brain stimulation for cervical dystonia: Effects on motor and non-motor symptoms within 5 years follow. J. Neurol Sci. 2023; 452: 120752. DOI: 10.1016/j.jns.2023.120752Albanese A. и др. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur. J. Neurol. 2006; 13 (5): 433–444. DOI: 10.1111/j.1468-1331.2006.01537.xAlbanese A. и др. A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force. Eur. J. Neurol. 2006; 13 (5): 433–444. DOI: 10.1111/j.1468-1331.2006.01537.xWilson T.J., Spinner R.J. Selective Cervical Denervation for Cervical Dystonia: Modification of the Bertrand Procedure. Operative Neurosurgery. 2018; 14 (5): 546–555. DOI: 10.1093/ons/opx147Wilson T.J., Spinner R.J. Selective Cervical Denervation for Cervical Dystonia: Modification of the Bertrand Procedure. Operative Neurosurgery. 2018; 14 (5): 546–555. DOI: 10.1093/ons/opx147Ravindran K., Ganesh Kumar N., Englot D.J., Wilson T.J., Zuckerman S.L. Deep Brain Stimulation Versus Peripheral Denervation for Cervical Dystonia: A Systematic Review and Meta-Analysis. World Neurosurg. 2019; 122: e940–e946. DOI:10.1016/j.wneu.2018.10.178Ravindran K., Ganesh Kumar N., Englot D.J., Wilson T.J., Zuckerman S.L. Deep Brain Stimulation Versus Peripheral Denervation for Cervical Dystonia: A Systematic Review and Meta-Analysis. World Neurosurg. 2019; 122: e940–e946. DOI:10.1016/j.wneu.2018.10.178Tassorelli C., Mancini F., Balloni L., Pacchetti C., Sandrini G., Nappi G., Martignoni E. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Movement Disorders 2006; 21 (12): 2240–2243. DOI: 10.1002/mds.21145Tassorelli C., Mancini F., Balloni L., Pacchetti C., Sandrini G., Nappi G., Martignoni E. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia. Movement Disorders 2006; 21 (12): 2240–2243. DOI: 10.1002/mds.21145Prudente C.N., Zetterberg L., Bring A., Bradnam L., Kimberley T. J. Systematic Review of Rehabilitation in Focal Dystonias: Classification and Recommendations. Mov Disord Clin Pract. 2018; 5 (3): 237–245. DOI: 10.1002/mdc3.12574Prudente C.N., Zetterberg L., Bring A., Bradnam L., Kimberley T. J. Systematic Review of Rehabilitation in Focal Dystonias: Classification and Recommendations. Mov Disord Clin Pract. 2018; 5 (3): 237–245. DOI: 10.1002/mdc3.12574Hashimoto Y., Ota T., Mukaino M., Liu M., Ushiba J. Functional recovery from chronic writer’s cramp by brain-computer interface rehabilitation: a case report. BMC Neurosci. 2014; 15: 103. DOI: 10.1186/1471-2202-15-103Hashimoto Y., Ota T., Mukaino M., Liu M., Ushiba J. Functional recovery from chronic writer’s cramp by brain-computer interface rehabilitation: a case report. BMC Neurosci. 2014; 15: 103. DOI: 10.1186/1471-2202-15-103De Pauw J., Van der Velden K., Meirte J., Van Daele U., Truijen S., Cras P., Mercelis R., De Hertogh W. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J. Neurol. 2014; 261 (10): 1857–1865. DOI: 10.1007/s00415-013-7220-8De Pauw J., Van der Velden K., Meirte J., Van Daele U., Truijen S., Cras P., Mercelis R., De Hertogh W. The effectiveness of physiotherapy for cervical dystonia: a systematic literature review. J. Neurol. 2014; 261 (10): 1857–1865. DOI: 10.1007/s00415-013-7220-8Loudovici-Krug D., Derlien S., Best N., Günther A. Physiotherapy for Cervical Dystonia: A Systematic Review of Randomised Controlled Trials. Toxins (Basel). 2022; 14 (11): 784. DOI: 10.3390/toxins14110784Loudovici-Krug D., Derlien S., Best N., Günther A. Physiotherapy for Cervical Dystonia: A Systematic Review of Randomised Controlled Trials. Toxins (Basel). 2022; 14 (11): 784. DOI: 10.3390/toxins14110784Zaghi S., de Freitas Rezende L., de Oliveira L.M., El-Nazer R., Menning S., Tadini L., Fregni F. Inhibition of motor cortex excitability with 15Hz transcranial alternating current stimulation (tACS). Neurosci Lett. 2010; 479 (3): 211–214. DOI: 10.1016/j.neulet.2010.05.060Zaghi S., de Freitas Rezende L., de Oliveira L.M., El-Nazer R., Menning S., Tadini L., Fregni F. Inhibition of motor cortex excitability with 15Hz transcranial alternating current stimulation (tACS). Neurosci Lett. 2010; 479 (3): 211–214. DOI: 10.1016/j.neulet.2010.05.060Ganguly J., Murgai A., Sharma S., Aur D., Jog M. Non-invasive Transcranial Electrical Stimulation in Movement Disorders. Front Neurosci. 2020; 14: 522. DOI: 10.3389/fnins.2020.00522Ganguly J., Murgai A., Sharma S., Aur D., Jog M. Non-invasive Transcranial Electrical Stimulation in Movement Disorders. Front Neurosci. 2020; 14: 522. DOI: 10.3389/fnins.2020.00522Bleton J.-P., Cossé C., Caloc’h T., Suarez Moreno A., Diverres E., Derkinderen P., Nizard J., Lefaucheur J.-P., Nguyen J.-P. Combination of anodal tDCS of the cerebellum with a goal-oriented motor training to treat cervical dystonia: a pilot case series. Front Neurol. 2024; 15: 1381390. DOI: 10.3389/fneur.2024.1381390Bleton J.-P., Cossé C., Caloc’h T., Suarez Moreno A., Diverres E., Derkinderen P., Nizard J., Lefaucheur J.-P., Nguyen J.-P. Combination of anodal tDCS of the cerebellum with a goal-oriented motor training to treat cervical dystonia: a pilot case series. Front Neurol. 2024; 15: 1381390. DOI: 10.3389/fneur.2024.1381390Pirio Richardson S., Tinaz S., Chen R. Repetitive transcranial magnetic stimulation in cervical dystonia: effect of site and repetition in a randomized pilot trial. PLoS One. 2015; 10 (4): e0124937. DOI: 10.1371/journal.pone.0124937Pirio Richardson S., Tinaz S., Chen R. Repetitive transcranial magnetic stimulation in cervical dystonia: effect of site and repetition in a randomized pilot trial. PLoS One. 2015; 10 (4): e0124937. DOI: 10.1371/journal.pone.0124937Sigrist C., Vöckel J., MacMaster F.P., Farzan F., Croarkin P.E., Galletly C., Kaess M., Bender S., Koenig J. Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. Eur. Child Adolesc Psychiatry. 2022; 31 (10): 1501–1525. DOI: 10.1007/s00787-022-02021-7Sigrist C., Vöckel J., MacMaster F.P., Farzan F., Croarkin P.E., Galletly C., Kaess M., Bender S., Koenig J. Transcranial magnetic stimulation in the treatment of adolescent depression: a systematic review and meta-analysis of aggregated and individual-patient data from uncontrolled studies. Eur. Child Adolesc Psychiatry. 2022; 31 (10): 1501–1525. DOI: 10.1007/s00787-022-02021-7Hallett M. Transcranial Magnetic Stimulation: A Primer. Neuron. 2007; 55 (2): 187–199. DOI: 10.1016/j.neuron.2007.06.026Hallett M. Transcranial Magnetic Stimulation: A Primer. Neuron. 2007; 55 (2): 187–199. DOI: 10.1016/j.neuron.2007.06.026Lefaucheur J.-P. и др. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clinical Neurophysiology. 2020; 131 (2): 474–528. DOI: 10.1016/j.clinph.2019.11.002Lefaucheur J.-P. и др. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014–2018). Clinical Neurophysiology. 2020; 131 (2): 474–528. DOI: 10.1016/j.clinph.2019.11.002Pirio Richardson S. Enhanced dorsal premotor–motor inhibition in cervical dystonia. Clinical Neurophysiology. 2015; 126 (7): 1387–1391. DOI: 10.1016/j.clinph.2014.10.140Pirio Richardson S. Enhanced dorsal premotor–motor inhibition in cervical dystonia. Clinical Neurophysiology. 2015; 126 (7): 1387–1391. DOI: 10.1016/j.clinph.2014.10.140Bologna M., Paparella G., Fabbrini A., Leodori G., Rocchi L., Hallett M., Berardelli A. Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia. Clinical Neurophysiology. 2016; 127 (11): 3472–3479. DOI: 10.1016/j.clinph.2016.09.008Bologna M., Paparella G., Fabbrini A., Leodori G., Rocchi L., Hallett M., Berardelli A. Effects of cerebellar theta-burst stimulation on arm and neck movement kinematics in patients with focal dystonia. Clinical Neurophysiology. 2016; 127 (11): 3472–3479. DOI: 10.1016/j.clinph.2016.09.008Zittel S., Helmich R.C., Demiralay C., Münchau A., Bäumer T. Normalization of sensorimotor integration by repetitive transcranial magnetic stimulation in cervical dystonia. J. Neurol. 2015; 262 (8): 1883–1889. DOI: 10.1007/s00415-015-7789-1Zittel S., Helmich R.C., Demiralay C., Münchau A., Bäumer T. Normalization of sensorimotor integration by repetitive transcranial magnetic stimulation in cervical dystonia. J. Neurol. 2015; 262 (8): 1883–1889. DOI: 10.1007/s00415-015-7789-1Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology. 2009; 120 (12): 2008–2039. DOI: 10.1016/j.clinph.2009.08.016Rossi S., Hallett M., Rossini P.M., Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology. 2009; 120 (12): 2008–2039. DOI: 10.1016/j.clinph.2009.08.016Schrader L.M., Stern J.M., Fields T.A., Nuwer M.R., Wilson C.L. A lack of effect from transcranial magnetic stimulation (TMS) on the vagus nerve stimulator (VNS). Clinical Neurophysiology. 2005; 116 (10): 2501–2504. DOI: 10.1016/j.clinph.2005.06.025Schrader L.M., Stern J.M., Fields T.A., Nuwer M.R., Wilson C.L. A lack of effect from transcranial magnetic stimulation (TMS) on the vagus nerve stimulator (VNS). Clinical Neurophysiology. 2005; 116 (10): 2501–2504. DOI: 10.1016/j.clinph.2005.06.025Loo C.K., McFarquhar T.F., Mitchell P.B. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. International Journal of Neuropsychopharmacology. 2008; 11 (1): 131–147. DOI: 10.1017/S1461145707007717Loo C.K., McFarquhar T.F., Mitchell P.B. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. International Journal of Neuropsychopharmacology. 2008; 11 (1): 131–147. DOI: 10.1017/S1461145707007717

The authors declare that there are no conflicts of interest present.